[1] KALOGIANNIDIS I,AGORASTOS T.Conservative management of young patients with endometrial highly-differentiated adenocarcinoma[J].J Obstet Gynaecol,2011,31(1):13-17. [2] BOKHMAN J V.Two pathogenetic types of endometrial carcinoma[J].Gynecol Oncol,1983,15(1):10-17. [3] 刘淑兰,孙建萍,毕宝亮.子宫内膜癌细胞学检查阳性与淋巴转移的关系研究[J].中国现代医学杂志,2018,28(11):107-111. [4] 赵绘萍,赵国库,周宏伟.子宫内膜癌术前MRI检查的价值[J].中国现代医学杂志,2008,18(1):93-95,98. [5] 王静,陈亦乐,贺国强.子宫内膜癌预后相关因素的探讨[J].中国现代医学杂志,1997(5):48-50. [6] ITO K,UTSUNOMIYA H,YAEGASHI N,et al.Biological roles of estrogen and progesterone in human endometrial carcinoma:new developments in potential endocrine therapy for endometrial cancer[J].Endocr J,2007,54(5):667-679. [7] 邱美婷,万小平.雄激素受体在激素依赖性肿瘤中的研究进展[J].医学综述,2015,21(9):1543-1546. [8] ZADEH S L,DUSKA L R,MILLS A M.Androgen receptor expression in endometrial carcinoma[J].Int J Gynecol Pathol,2018,37(2):167-173. [9] 李小毛,杨晓辉.子宫内膜癌的治疗进展[J].中国现代手术学杂志,2013,17(1):76-79. [10] 王丽琴.子宫内膜癌临床诊治的研究进展[J].中国肿瘤临床与康复,2012,19(5):472-474. [11] 吴焕文,梁智勇,张卉,等.子宫内膜癌免疫组化标记物的研究进展[J].诊断病理学杂志,2013,20(3):180-183. [12] 林仲秋,吴珠娜.FIGO 2009外阴癌、宫颈癌和子宫内膜癌新分期解读[J].国际妇产科学杂志,2009,36(5):411-412. [13] TANAKA S,MIKI Y,HASHIMOTO C,et al.The role of 5alpha-reductase type Ⅰ associated with intratumoral dihydrotestosterone concentrations in human endometrial carcinoma[J].Mol Cell Endocrinol,2015,401:56-64. [14] 孙丹丹,王颖梅,张慧英,等.子宫内膜癌雄激素受体表达及临床意义[J].实用妇产科杂志,2012,28(2):131-134. [15] 吴迪,杨成喜.雄激素对子宫内膜癌抑制作用的研究进展[J].癌症进展,2018,16(5):536-538. [16] 孙丹丹.子宫内膜癌雄激素受体表达及其与ER、PR表达的相关性研究[D].天津:天津医科大学,2012. [17] CENTOLA G M.Inhibition of endometrial carcinoma cell cultures by a synthetic androgen[J].Cancer Res,1985,45(12 Pt 1):6264-6267. [18] FENG W,YANG C X,ZHANG L,et al.Curcumin promotes the apoptosis of human endometrial carcinoma cells by downregulating the expression of androgen receptor through Wnt signal pathway[J].Eur J Gynaecol Oncol,2014,35(6):718-723. [19] SASAKI M,DAHIYA R,FUJIMOTO S,et al.The expansion of the CAG repeat in exon 1 of the human androgen receptor gene is associated with uterine endometrial carcinoma[J].Mol Carcinog,2000,27(3):237-244. [20] 周党侠.雄激素受体与妇科肿瘤[J].国外医学(妇幼保健分册),2002(3):123-124. [21] 郑巳年,傅广波.雄激素受体与生殖系统肿瘤[J].国际生殖健康/计划生育杂志,2014,33(6):443-447.